Rhenman & Partners Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
2018
Q3
$97K Hold
2018
Q2
$325K Hold
2018
Q1
$354K Hold
2017
Q4
$513K Sell
2017
Q3
$725K Sell
2017
Q2
$585K Hold
2017
Q1
$979K Buy
2016
Q4
$1.05M Buy
2016
Q3
$990K Sell
2016
Q2
$1.01M Buy
2016
Q1
$1.39M Hold
2015
Q4
$1.74M Hold
2015
Q3
$1.31M Buy